The epithelial-mesenchymal transition (EMT) is a developmental process during which epithelial cells lose polarity, cell-cell contacts, and other epithelial characteristics and acquire properties (such as increased motility) that are typical of mesenchymal cells. Common EMT features include loss of E-cadherin at the plasma membrane, increased nuclear β-catenin, gain of vimentin and fibronectin expression, and a fibroblastoid morphology. EMT is critical for morphogenetic events, including gastrulation and organogenesis, and is also likely to be involved in processes such as tissue repair and cancer invasion (Thiery and Sleeman 2006) . Many different signaling pathways have been implicated in EMT, including receptor tyrosine kinases, transforming growth factor β (TGFβ), Notch, and Wnt (Thiery and Sleeman 2006) . In this issue of Cell, Yang et al. (2006b) reveal a new player in the EMT network, p68 RNA helicase.
p68 belongs to the DEAD-box family of RNA helicases that are conserved throughout evolution (Rocak and Linder 2004) . RNA helicases including p68 exhibit RNA-dependent ATPase activity that unwinds RNA structures or dissociates RNAprotein interactions, thereby participating in events such as transcription, splicing, and translation (Rocak and Linder 2004) . Phosphorylation of p68 is prevalent in many cancercell lines but not in normal tissues (Yang et al., 2005) , implying that the regulation of p68 by phosphorylation may participate in growth control. Indeed, in HT-29 colon cancer cells, PDGF induces rapid phosphorylation of p68 on tyrosine 593 by the c-Abl kinase, which associates with p68 upon PDGF signaling (Yang et al., 2006b ; Figure 1 ).
PDGF induces EMT in HT-29 colon cancer cells, as determined by loss of epithelial cell-cell contacts and cell scattering, and by loss of Ecadherin and gain of vimentin and fibronectin expression (Yang et al., 2006b ). Depletion of p68 using small interfering RNAs (siRNAs) prevented EMT, which was rescued by reintroduction of p68 but not by introduction of a p68 mutant in which tyrosine 593 was replaced with phenylalanine (Y593F). Importantly, when delivered into cells as recombinant proteins, p68 that had been phosphorylated by c-Abl in vitro, but neither unphosphorylated p68 nor p68(Y593F), was sufficient to induce EMT (Yang et al., 2006b) . Thus, phosphorylation of p68 on tyrosine 593 is necessary and sufficient for PDGF-induced EMT.
β-catenin plays two critical roles in cells: it regulates cell adhesion through association with E-cadherin at the plasma membrane, and it also activates transcription in the nucleus in response to Wnt signaling. There-
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Other components of the Axin complex, such as CK1 and APC, are not shown.
fore, β-catenin is a key regulator of EMT (Brembeck et al., 2006) . Yang et al. (2006b) found that p68 phosphorylated on tyrosine 593 but not unphosphorylated p68, binds to β-catenin (Figure 1 ), and that the interaction was required for PDGFinduced β-catenin nuclear localization. In fact, the authors observed a temporal order of p68-complex formation upon PDGF induction: the p68-c-Abl complex and accompanying p68 phosphorylation were followed by the disappearance of the complex and the appearance of the p68-β-catenin association ( Figure  1 ). The nuclear β-catenin was not simply a consequence of E-cadherin downregulation during EMT, because phosphorylated p68 promoted β-catenin nuclear localization regardless of whether E-cadherin was depleted or overexpressed (Yang et al., 2006b ). How does phosphorylated p68 lead to nuclear localization of β-catenin?
We rewind briefly to review how Wnt activates nuclear β-catenin signaling. In the absence of Wnt, cytosolic β-catenin (not E-cadherinassociated β-catenin) is recruited to a "destruction" complex that includes the scaffolding protein Axin, the tumor suppressor APC, and CK1 and GSK3 kinases, which sequentially phosphorylate β-catenin, thus triggering its degradation. (Note that although HT29 cells harbor a truncated APC protein, β-catenin phosphorylation and degradation can still occur [Yang et al., 2006a] ). Activation of the Wnt-signaling pathway inhibits GSK3 phosphorylation of β-catenin, probably by disrupting the Axin-GSK3-β-catenin complex , thereby resulting in β-catenin accumulation and its ensuing nuclear localization. β-catenin then acts as a coactivator for LEF/TCF transcription factors (Brembeck et al., 2006) . Yang et al. (2006b) provide evidence suggesting that phosphorylated p68 promotes β-catenin nuclear accumulation via the regulation of the Axin complex, but with some interesting twists. Phosphorylated p68 inhibited β-catenin phosphorylation by GSK3 in vitro and in vivo. Experiments using monoclonal antibodies (mAbs) to block the p68-β-catenin interaction suggested that phosphorylated p68 might inhibit β-catenin phosphorylation via binding to the β-catenin amino terminus, where GSK3-phosphorylation sites reside. This interpretation, however, requires caution due to technical caveats such as the efficiency of delivering different mAbs into cells. Yang et al. (2006b) realized that an additional mechanism must be at work. Given that p68 is an ATPase, the authors tested the effect of p68 mutants that lack ATPase activity on β-catenin nuclear accumulation. These mutants failed to induce the translocation of β-catenin into the nucleus despite being able to bind to β-catenin. Subsequent experiments, both in vitro and in vivo, suggested two separable activities of phosphorylated p68. This RNA helicase dissociates GSK3 from the Axin complex in an ATPase-independent manner. It then further dissociates β-catenin from the Axin complex via its ATPase activity (Figure 1) . Presumably, either of these two p68 activities is sufficient to inhibit β-catenin phosphorylation by GSK3, but the data argue that displacement of β-catenin from Axin is required for β-catenin accumulation in the nucleus. This distinction is of interest, as it echoes the observation in Drosophila embryos that Axin has a key role in anchoring β-catenin in the cytoplasm (Tolwinski and Wieschaus 2001). Finally, Yang et al. (2006b) demonstrate that EMT induced by phosphorylated p68 requires both nuclear β-catenin and the transcription factor TCF-1.
This study has uncovered a new EMT pathway from PDGF, via c-Abl and p68, to nuclear β-catenin. Given that EGF (which, like PDGF, signals via a receptor tyrosine kinase) and TGFβ (which signals via serine/threonine kinase receptors) also induce p68 tyrosine phosphorylation and require p68 for EMT induction in cultured kidney epithelial cells (Yang et al., 2006b) , the p68-β-catenin axis may represent a common output for several signaling pathways. These pathways offer additional routes to nuclear β-catenin signaling that are parallel to the Wnt pathway, which does not involve p68 (Yang et al., 2006b) . Other routes to β-catenin nuclear accumulation also exist. For example, phosphorylation of β-catenin at tyrosine 142 by Met (also a receptor tyrosine kinase), Fer, or Fyn kinase diminishes β-catenin affinity for α-catenin in the E-cadherin complex but enhances β-catenin binding to the transcriptional coactivator Bcl9-2, thereby leading to increased nuclear β-catenin signaling and EMT (Brembeck et al., 2006) . It remains unclear whether these pathways operate independently or in concert.
Where and how p68 acts to elicit nuclear β-catenin localization deserves further investigation. p68 is predominantly a nuclear protein, and formation of the p68-c-Abl complex and subsequent p68 phosphorylation at tyrosine 593 was observed in the nucleus (Yang et al., 2006b) . Given that it is generally believed that β-catenin phosphorylation and degradation by the Axin-GSK3 complex occurs in the cytoplasm, and that some p68 could be detected in the cytosolic fraction upon PDGF treatment, the authors propose that phosphorylated p68 exits from the nucleus and acts in the cytoplasm to displace β-catenin from the Axin complex (Yang et al., 2006b ). But other scenarios remain possible. For example, phosphorylated p68 may act in the nucleus (1) as a β-catenin retention partner and (2) to prevent export of β-catenin into the cytoplasm by Axin and/or APC (Bienz 2002; Cong and Varmus, 2004) . Indeed, some studies have suggested that cytoplasmic versus nuclear retention plays a major role in β-catenin localization (e.g., Tolwinski and Wieschaus 2001; Krieghoff et al., 2006) . Notably, there are remarkable similarities between phosphorylated p68 and Bcl9-2 in β-catenin binding and nuclear localization, and in the induction of EMT (Brembeck et al., 2006) . Does Bcl9-2 also regulate the Axin-β-catenin complex directly? Can p68, like Bcl9-2, act as a β-catenin coactivator?
How p68, an RNA-dependent ATPase, is regulated remains unknown (Rocak and Linder 2004) . If ATP hydrolysis by p68 is required for displacement of β-catenin from Axin as suggested but yet to be demonstrated by Yang et al. (2006b) , is it possible that the Axin complex contains an RNA that activates p68 ATPase? Or is p68 a protein-dependent (more specifically, β-catenin-dependent) ATPase as well? Tyrosine 593 of p68 is conserved in vertebrates (but not in invertebrates) and is located in the p68 carboxyl terminus outside the globular catalytic core (Rocak and Linder 2004) . Does phosphorylation at this site regulate p68 catalytic function in addition to providing an interaction interface for β-catenin? Finally, as EMT has been implicated in cancer invasion (Thiery and Sleeman 2006) , inhibitors of the c-Abl-p68-β-catenin pathway may be beneficial in preventing metastasis of tumor cells. In this regard, it is worth considering whether STI571/Gleevac-which inhibits c-Abl (and PDGF) signaling and is a potent anti-cancer drug for certain blood and solid tumors-may act in part by inhibiting the p68-β-catenin pathway and whether Gleevec may exhibit efficacy in preventing metastasis of other cancer types.
Studies in many different areas of cancer research including epidemiological studies have established the connection between inflammation and cancer (Balkwill et al., 2005; Balkwill and Mantovani, 2001; Coussens and Werb, 2002) . For example, inflammatory bowel disease is a risk factor for the development of colorectal cancer. Moreover, the usage of nonsteroid anti-inflammatory agents is associated with protection against various tumors, and these drugs have been investigated as possible anticancer agents. Even tumors where a firm connection to inflammation has not been established, such as breast cancer, exhibit an inflammatory microenvironment at the site of the tumor. Indeed, an inflammatory component is present in the microenvironment of most neoplastic tissues. In this context, Chien et al. (2006) now identify a signaling pathway mediated by the RalB GTPase that regulates both tumor survival and the inflammatory response.
Many of the inflammatory factors that promote tumorigenesis are generated by cells in the tumor microenviroment, and not by the cancer cells themselves (called the "extrinsic" pathway in Figure 1 ) (Balkwill et al., 2005; Balkwill and Mantovani, 2001; Coussens and Werb, 2002 A connection between the genetic events that lead to tumor formation and the signaling pathways of the innate immune response has been established. In this issue, Chien et al. (2006) show that the RalB GTPase regulates the IKK family member TBK1, providing an unexpected link between the signaling pathways that promote inflammation and cancer. In tumor cells the RalB/TBK1 pathway inhibits apoptosis and in nontumorigenic cells it stimulates an innate immune response.
